Sort
39,280 grants matching “leukemia”
HSV-1 TK MODIFIED T CELLS FOR GRAFT VERSUS LEUKEMIA
$405,860University Of Pennsylvania · P50 · FY2000 · HL
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
$405,847Michele S. Redell · Baylor College Of Medicine · R01 · FY2014 · CA
Characterizing stem cell-like B cell subpopulations and dissecting their role in tumorigenesis
$405,817Effie Apostolou · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Structural basis of Jak3-mediated interleukin-2 family signal transduction
$405,786Titus Jonathon Boggon · Yale University · R01 · FY2008 · AI
Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia
$405,775Mrinal Shiv Patnaik · Mayo Clinic Rochester · R01 · FY2024 · CA
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
$405,748Birgit Knoechel · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
$405,748Birgit Knoechel · Dana-Farber Cancer Inst · R01 · FY2022 · CA
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN
$405,711St. Jude Children'S Research Hospital · R01 · FY2001 · CA
Biology and therapeutic targeting of zinc finger transcription factors in AML
$405,564Scott A Armstrong · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Development of Next-Generation Precision Medicine RNAi Therapeutics to Treat AML
$405,557Steven F Dowdy · University Of California, San Diego · R21 · FY2020 · CA
MOLECULAR MECHANISMS OF NUCLEIC ACID DAMAGE BY ENEDIYNES
$405,517Irving H Goldberg · Harvard Medical School · R01 · FY2006 · GM
Regulation of CXCR4 by cognate and non-cognate ligands
$405,516Elias Lolis · Yale University · R01 · FY2012 · AI
Rac proteins in hematopoietic cell survival and function
$405,494David A Williams · Boston Children'S Hospital · R01 · FY2013 · DK
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD
$405,493George F Murphy · Brigham And Women'S Hospital · R01 · FY2024 · HL
Innovative Cell Therapy for Pediatric Acute Myeloid Leukemia
$405,486Maria Grazia Roncarolo · Stanford University · R21 · FY2020 · CA
Understanding and predicting relapse in acute myeloid leukemia
$405,460Jerald P Radich · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Biochemistry of Leukemia Virus Core Binding Factor
$405,444Nancy Asmussen Speck · Dartmouth College · R01 · FY2007 · CA
Mechanism of inv(16) mediated leukemogenesis
$405,438Scott Hiebert · Vanderbilt University · R01 · FY2008 · CA
Biochemistry of Leukemia Virus Core Binding Factor
$405,389Nancy Asmussen Speck · Dartmouth College · R01 · FY2006 · CA
Epigenetic Modulation of GvHD and GvL
$405,388John F Dipersio · Washington University · P50 · FY2016 · CA
Leukemogenic Slug Pathway in Hematopoietic Cell Survival
$405,347A Thomas Look · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Antiretroviral Activity of TRIM5alpha
$405,347Joseph G Sodroski · Dana-Farber Cancer Inst · R01 · FY2007 · AI
Leukemogenic Slug Pathway in Hematopoietic Cell Survival
$405,347A Thomas Look · Dana-Farber Cancer Inst · R01 · FY2007 · CA
ROLE OF SHORT TELOMERES IN GENOMIC INSTABLITIY AND TUMOR INITIATION
$405,339Carol W Greider · Johns Hopkins University · P01 · FY2010 · CA
Differential Gel Electrophoresis (DIGE) System
$405,284Erol E Gulcicek · Yale University · S10 · FY2006 · RR